We use essential cookies and third-party cookies for content.

The National Times - Aston Martin slashes staff as US tariffs hit carmakers

Aston Martin slashes staff as US tariffs hit carmakers

ECONOMY 25.02.2026
Aston Martin slashes staff as US tariffs hit carmakers
Aston Martin slashes staff as US tariffs hit carmakers / Photo: © AFP

British luxury carmaker Aston Martin Lagonda on Wednesday announced plans to cut up to 20 percent of its workforce after widening annual losses on US tariffs and weak Chinese demand.

Change text size:

The job losses total around 600, with Aston Martin employing some 3,000 people, mostly in the UK.

The carmaker, which has struggled for several years, added in a statement that its net loss jumped 52 percent last year to £493.2 million ($667 million), compared with 2024.

Group annual revenue dropped 21 percent to £1.258 billion as car sales for the brand beloved by fictional British spy James Bond fell 10 percent to 5,448.

- 'Turbulent year' -

Aston Martin said its latest cost-cutting "programme will ultimately see the departure of up to 20 percent of our valued workforce".

Group chief executive Adrian Hallmark added that the global luxury automotive market last year "faced one of its most turbulent years in recent times".

"Consumer demand was impacted by escalating geopolitical uncertainties and macroeconomic challenges, the most notable being the introduction of increased tariffs in both the United States and China."

Automakers had been among the companies hit hardest by the US tariffs onslaught in 2025 as President Donald Trump sought to bring auto production back to the United States.

Aston Martin limited imports to the US in April and May while awaiting a trade agreement between London and Washington.

It resumed shipments in June after the deal slashed tariffs on UK car exports to 10 percent from 27.5 percent, on a limit of 100,000 vehicles annually.

Aston Martin on Wednesday said that the outlook for the automotive industry "remains challenging" amid "uncertainties over the economic impact from the unpredictable threat or introduction of additional US tariffs, changes to China's ultra-luxury car taxes and the continued reliance on a stable network of global suppliers".

The group added that "while China remains a market with long-term growth potential, demand there remained extremely subdued in line with other luxury automotive peers".

- Share price up -

Aston Martin expects "material improvement in financial performance" this year, "driven by an enhanced product mix, benefits from the ongoing transformation programme and disciplined approach to operations".

The group's share price rose slightly in London following the updates.

"The poor performance is being blamed on external factors, such as US tariffs and macroeconomic uncertainty," noted Aarin Chiekrie, an equity analyst at Hargreaves Lansdown.

"But looking under the hood reveals some internal issues, making Aston Martin's road to redemption more difficult.

"Production delays hampered the group's performance, leading to multiple profit downgrades over the last year," he added.

Faced with financial difficulty, Aston Martin last week said it would sell the naming rights to the Aston Martin Formula One team for £50 million.

Aston Martin Lagonda's biggest shareholder is the Yew Tree Consortium, led by Canadian Lawrence Stroll, whose son Lance Stroll drives for the Formula One team.

P.Barry--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: